3D-printed, fully synthetic neonatal surgical training platform with AI-driven assessment in develop
InfantSim combines 3D-printed neonatal anatomy and synthetic tissues to help surgeons master complex procedures outside the OR.
InfantSim’s planned B2B model combines simulator sales with recurring revenue from replaceable synthetic tissue modules, pathology packs and
Surgeons lack realistic neonatal simulators to practise rare, complex procedures and build essential skills outside the operating room.
EIC funding secured; PCT filed; prototype built and tested. Next: multicenter validation, sensor integration and pilot sales in 2027.
InfantSim offers anatomically accurate, fully synthetic neonatal simulation for repeatable hands-on surgical training outside the OR.
LAPARO, eoSim/SurgTrac and VR simulators. InfantSim differentiates through neonatal anatomy, synthetic tissues and modular pathology models.
Modular, 3D-printed neonatal surgical simulator with replaceable synthetic tissues for hands-on laparoscopic and thoracoscopic training.
With or without investment — figures provided by the founders.
We are raising €500,000 in pre-seed funding to co-finance our EIC project, advance international validation, develop Gen-2 simulators and integrate AI. We seek clinical partners, investors and a COO to lead production, sales and international rollout.
Anatomically accurate neonatal models, fully synthetic tissues, modular pathologies and sensor integration for future AI assessment.
Pediatric hospitals, simulation centers, universities and surgical training centers, with future expansion into robotic surgery training.
Direct B2B sales through clinical partnerships, pilot programs, congress demos and workshops, followed by international distributors.
Global neonatal and pediatric surgical simulation market, initially targeting hospitals, universities and simulation centers in Europe and U
Build awareness through surgical congresses, hands-on demos, publications, LinkedIn and partnerships with surgical opinion leaders.
